An outbreak of Ralstonia pickettii bloodstream infection and clinical outcomes
Related Experiment Video
Updated: Sep 23, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Şirin Menekşe1, Demet Hacıseyitoğlu2, Serap Süzük Yıldız3
1Department of Infectious Diseases, Koşuyolu Kartal Heart Training and Research Hospital, İstanbul, Turkey. meneksesirin@hotmail.com.
Introduction:
Ralstonia pickettii infections are rare and may be mistaken for other bacteria. This study aims to report a hospital outbreak of R. pickettii at a tertiary hospital, which was initially misidentified as Ralstonia insidiosa, along with its clinical consequences.
Methodology:
A bacteraemia outbreak occurred between August 14 and October 4, 2019, infecting 22 patients admitted to diverse intensive care units. All isolates were identified with the use of the automated VITEK 2 Compact system and were then subjected to a microbial identification system, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Bacterial identification and genomic DNA typing was made using pulsed-field gel electrophoresis. Investigation covered all potential sources of the outbreak.
Results:
An index patient and five additional patients developed fever while receiving care. Blood cultures of these patients yielded R. insidiosa by the VITEK 2 Compact system. Culture isolates were then submitted to a reference centre for confirmation by the MALDI-TOF MS system, where the bacterium turned out to be R. pickettii. No pathogen was isolated in the commercial products except for three samples of unopened sterile distilled water. Despite its discontinuation, 16 new cases were identified, in which blood cultures grew R. pickettii by the MALDI-TOF MS system. Attempts to uncover the source of the outbreak failed. Clinical manifestation was confined to fever in all the patients.
Conclusions:
During this outbreak, R. pickettii infections ran a relatively mild course without clinical deterioration or mortality, possibly due to low virulence.
Insights
A hospital outbreak of Ralstonia pickettii (R. pickettii) infections, initially misidentified as Ralstonia insidiosa, affected 22 patients. The infections were mild, with fever as the only symptom, and no mortality occurred.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Hospital Epidemiology
Background:
- Ralstonia pickettii (R. pickettii) infections are uncommon and can be misdiagnosed.
- Hospital outbreaks of R. pickettii are rare and pose diagnostic challenges.
Purpose of the Study:
- To report a hospital outbreak of R. pickettii infections.
- To describe the clinical consequences and initial misidentification of the outbreak.
- To investigate the source and spread of R. pickettii within a tertiary hospital.
Main Methods:
- A bacteraemia outbreak was investigated between August and October 2019.
- Isolates were identified using VITEK 2 Compact and MALDI-TOF MS.
- Genomic DNA typing was performed using pulsed-field gel electrophoresis.
- Potential sources, including commercial products, were examined.
Main Results:
- Twenty-two patients in intensive care units developed R. pickettii bacteraemia.
- Initial identification by VITEK 2 Compact misidentified R. pickettii as R. insidiosa.
- Sterile distilled water samples yielded R. pickettii, but the source remained unconfirmed.
- All patients presented with fever; no clinical deterioration or mortality was observed.
Conclusions:
- Ralstonia pickettii infections during this outbreak exhibited low virulence.
- Prompt and accurate identification using MALDI-TOF MS is crucial for managing R. pickettii outbreaks.
- Despite challenges in source identification, the clinical course was mild, suggesting a need for further research into R. pickettii virulence factors.
More Related Videos
11:25Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
Published on: October 15, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis II: Clinical Features of Infective Endocarditis
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies